4//SEC Filing
Newman Mark 4
Accession 0001627223-21-000051
CIK 0001627223other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:05 PM ET
Size
9.7 KB
Accession
0001627223-21-000051
Insider Transaction Report
Form 4
Newman Mark
SVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2021-12-02$18.45/sh+34,252$631,949→ 179,710.58 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-02−34,252→ 0 totalExercise: $18.45Exp: 2022-02-03→ Common Stock (34,252 underlying) - Sale
Common Stock
2021-12-02$29.94/sh−34,252$1,025,505→ 145,458.58 total
Holdings
- 2,480(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
- [F2]Includes directly owned shares, restricted stock units, and dividend equivalent units.
- [F3]Shares were sold in multiple transactions at prices ranging from $29.51 to $30.16.
- [F4]Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001524597
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:05 PM ET
- Size
- 9.7 KB